Pressor response to fluid resuscitation in endotoxic shock: Involvement of vasopressin

Critical Care Medicine

Volumn 37, Issue 11, 2009, Pages 2968-2972

  Batista, Mariana B ^a   Bravin, Augusto C ^b   Lopes, Lais M ^a   Gerenuti, Elisa ^a   Elias, Lucila L K ^b   Antunes Rodrigues, Jose ^b   Giusti Paiva, Alexandre ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood volume expansion; Endotoxin; Hypertonic saline; Hypotension; Sepsis; Shock

Indexed keywords

HETASTARCH; HYPERTENSIVE FACTOR; HYPERTONIC SOLUTION; ISOTONIC SOLUTION; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BLOOD VOLUME; CONTROLLED STUDY; FLUID RESUSCITATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT; SEPTIC SHOCK; VASOPRESSIN RELEASE;

EID: 73449134786     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b02e3b     Document Type: Article

References (40)

1. Teles JM, Silva E, Westphal G, et al: Surviving sepsis campaign in Brazil. Shock 2008; 30(Suppl 1):47-52
2. Hasibeder WR: Fluid resuscitation during capillary leakage: does the type of fluid make a difference. Intensive Care Med 2002; 28: 532-534
3. Oliveira RP, Weingartner R, Ribas EO, et al: Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Med 2002; 28:1574-1581
4. Oliveira RP, Velasco I, Soriano F, et al: Hy-pertonic saline resuscitation in sepsis. Crit Care 2002; 6:418-423
5. Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 2003; 31: 946-955
6. Su F, Wang Z, Cai Y, et al: Fluid resuscitation in severe sepsis and septic shock: albumin, hydroxyethyl starch, gelatin or ringer's lac-tate-does it really make a difference? Shock 2007; 27:520-526
7. Drobin D, Hahn RG: Kinetics of isotonic and hypertonic plasma volume expanders. Anes-thesiology 2002; 96:1371-1380
8. Kramer GC: Hypertonic resuscitation: physiologic mechanisms and recommendations for trauma care. J Trauma 2003; 54:S89-S99
9. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
10. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34:17-60
11. Russell JA, Walley KR, Singer J, et al: Vaso-pressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
12. Ventura RR, Giusti-Paiva A, Gomes DA, et al: Neuronal nitric oxide synthase inhibition differentially affects oxytocin and vasopressin secretion in salt loaded rats. Neurosci Lett 2005; 379:75-80
13. Antunes-Rodrigues J, de Castro M, Elias LL, et al: Neuroendocrine control of body fluid metabolism. Physiol Rev 2004; 84:169-208
14. Holmes CL, Patel BM, Russell JA, et al: Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989-1002
15. Barrett LK, Singer M, Clapp LH: Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007; 35:33-40
16. Giusti-Paiva A, Martinez MR, Bispo-da-Silva LB, et al: Vasopressin mediates the pressor effect of hypertonic saline solution in endo-toxic shock. Shock 2007; 27:416-421
17. Giusti-Paiva A, De Castro M, Antunes-Rodrigues J, et al: Inducible nitric oxide syn-thase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med 2002; 30: 1306-1310
18. Fregoneze JB, Salgado MC, Castro e Silva EJ, et al: Hypertensive response to acute aortic coarctation in chronic vasopressin deficient states. Clin Exp Hypertens 1995; 17:977-988
19. Elias LL, Antunes-Rodrigues J, Elias PC, et al: Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus. J Clin Endocrinol Metab 1997; 82:1243-1247
20. Hoffmann JN, Vollmar B, Laschke MW, et al: Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcir-culation during normotensive endotoxemia. Anesthesiology 2002; 97:460-470
21. Schäper J, Ahmed R, Schäfer T, et al: Volume therapy with colloid solutions preserves intestinal microvascular perfusion in endotox-aemia. Resuscitation 2008; 76:120-128
22. Pettersson A, Ricksten SE, Towle AC, et al: Haemodynamics and plasma ANP after acute blood volume expansion in normotensive and spontaneously hypertensive rats. Acta Physiol Scand 1988; 133:513-518
23. Anderson JV, Christofides ND, Bloom SR: Plasma release of atrial natriuretic peptide in response to blood volume expansion. J En-docrinol 1986; 109:9-13
24. Godino A, Giusti-Paiva A, Antunes-Rodrigues J, et al: Neurochemical brain groups activated after an isotonic blood volume expansion in rats. Neuroscience 2005; 133: 493-505
25. Haanwinckel MA, Elias LK, Favaretto AL, et al: Oxytocin mediates atrial natriuretic pep-tide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci USA 1995; 92:7902-7906
26. Thomas CJ, May CN, Sharma AD, et al: ANP, BNP, and CNP enhance bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep. Am J Physiol Regul Integr Comp Physiol 2001; 280: R282-R288
27. Michelini LC, Marcelo MC, Amico J, et al: Oxytocinergic regulation of cardiovascular function: studies in oxytocin-deficient mice. Am J Physiol Heart Circ Physiol 2003; 284: H2269-H2276
28. Poli-de-Figueiredo LF, Cruz RJ, Jr., San-nomiya P, et al: Mechanisms of action of hypertonic saline resuscitation in severe sepsis and septic shock. Endocr Metab Immune Disord Drug Targets 2006; 6:201-206
29. Velasco IT, Pontieri V, Rocha e Silva M Jr, et al: Hyperosmotic NaCl and severe hemor-rhagic shock. Am J Physiol 1980; 239: H664-H673
30. Grocott MP, Hamilton MA: Resuscitation fluids. Vox Sang 2002; 82:1-8
31. Sharshar T, Blanchard A, Paillard M, et al: Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31:1752-1758
32. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the va-sodilation of septic shock. Circulation 1997; 95:1122-1125
33. Giusti-Paiva A, Elias LL, Antunes-Rodrigues J: Inhibitory effect of gaseous neuromodula-tors in vasopressin and oxytocin release induced by endotoxin in rats. Neurosci Lett 2005; 381:320-324
34. Batalhão ME, Moreto V, Stabile AM, et al: Role of dexamethasone on vasopressin release during endotoxemic shock. Regul Pept 2008; 147:67-71
35. Remick DG, Ward PA: Evaluation of endo-toxin models for the study of sepsis. Shock 2005; 24Suppl 1:7-11
36. Lv R, Zhou ZQ, Wu HW, et al: Hydroxyethyl starch exhibits antiinflammatory effects in the intestines of endotoxemic rats. Anesth Analg 2006; 103:149-155
37. Kü pper S, Mees ST, Gassmann P, et al: Hy-droxyethyl starch normalizes platelet and leukocyte adhesion within pulmonary micro-circulation during LPS-induced endotox-emia. Shock 2007; 28:300-308
38. Inoue Y, Chen Y, Pauzenberger R, et al: Hy-pertonic saline up-regulates A3 adenosine receptor expression of activated neutrophils and increases acute lung injury after sepsis. Crit Care Med 2008; 36:2569-2575
39. Boldt J, Suttner S: Plasma substitutes. Minerva Anestesiol 2005; 71:741-758
40. Shukla A, Hashiguchi N, Chen Y, et al: Osmotic regulation of cell function and possible clinical applications. Shock 2004; 21: 391-400